KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UiPath (PATH) Cash & Equivalents: 2021-2025

Historic Cash & Equivalents for UiPath (PATH) over the last 5 years, with Jan 2025 value amounting to $879.2 million.

  • UiPath's Cash & Equivalents fell 3.87% to $743.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $743.7 million, marking a year-over-year decrease of 3.87%. This contributed to the annual value of $879.2 million for FY2025, which is 17.19% down from last year.
  • Per UiPath's latest filing, its Cash & Equivalents stood at $879.2 million for FY2025, which was down 17.19% from $1.1 billion recorded in FY2024.
  • UiPath's 5-year Cash & Equivalents high stood at $1.8 billion for FY2022, and its period low was $357.7 million during FY2021.
  • For the 3-year period, UiPath's Cash & Equivalents averaged around $1.1 billion, with its median value being $1.1 billion (2024).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 394.48% in 2022, then dropped by 24.28% in 2024.
  • Yearly analysis of 5 years shows UiPath's Cash & Equivalents stood at $357.7 million in 2021, then spiked by 394.48% to $1.8 billion in 2022, then dropped by 20.73% to $1.4 billion in 2023, then declined by 24.28% to $1.1 billion in 2024, then decreased by 17.19% to $879.2 million in 2025.